| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919826 | Radiotherapy and Oncology | 2011 | 4 Pages |
Abstract
Depression was mildly increased in patients receiving hormonal therapy. The increase appeared to be related to both the hormone therapy itself and the high risk status of patients. High risk status, with the associated poor prognosis, had a more sustained effect on depression. The rise was statistically significant, but was too small, however, to bear clinical significance.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Julia J. van Tol-Geerdink, Jan Willem Leer, Emile N.J.T. van Lin, Erik C. Schimmel, Peep F.M. Stalmeier,